ALK Genes
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| An Integrated Approach to Treating Recurrent Thoracic Carcinomas Resistant to Tyrosine Kinase Inhibitors (NCT02616211) | Mayo Clinic | 2014-10-01 |
Track ALK Genes automatically
Every clearance here is in the API, with alerts when new ones post.